Geron Corp (NASDAQ:GERN) - Share price - Overview

Stock Report

Geron Corp GERN

Last Price
$2.20

Day Change
-0.08|-3.51%

As of 21/02/2017
16:00:00 EST | USD
Minimum 15 Minutes Delay.

Last Close2.28
Day Range2.18 - 2.29
Mkt Cap350.10Mil
52-Wk Range1.81 - 3.35
Yield %-
ISINUS3741631036
Volume949,955
P/E-12.24
P/S55.87
P/CF-15.30

Share Price

Financials
201320142015
More ...
Income Statement
Revenue1.281.1536.37
Operating Income-38.96-36.31-0.56
Net Income-38.38-35.670.05
Basic EPS-0.30-0.230.00
Avg. Diluted Shares Outstanding128154163
Balance Sheet
Current Assets67.06153.41115.89
Non Current Assets0.2919.1132.87
Total Assets67.34172.51148.76
Current Liabilities7.5941.806.63
Total Liabilities7.5941.806.63
Total Equity59.76130.71142.13
Cash Flow
Operating Cash Flow-36.689.35-24.20
Capital Expenditure0.00-0.13-0.09
Free Cash Flow-36.689.22-24.29

In millions, except "Basic EPS". Currency is USD.

Company Profile

Geron Corp is a biopharmaceutical company that supports the clinical stage development of a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies, by Janssen Biotech, Inc., or Janssen.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Growth

Fiscal Year Ends

December

Employees

17
Key Stats
More ...
Price/Earning TTM-12.69
Price/Book2.81
Price/Sales TTM58.02
Rev Growth (3 year avg)137.67
EPS Growth (3 year avg)-
Operating Margin % TTM-1.54
Net Margin % TTM0.13
ROE TTM0.03
Debt/Equity-
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.